2-Year U.S. Treasury Note Continuous Contract $101.492-0.020-0.02% 5-Year U.S. Treasury Note Continuous Contract $105.125-0.078-0.07% 10-Year U.S. Treasury Note Continuous Contract $107.969-0.141 ...
Optinose (NASDAQ:OPTN), a specialty pharmaceutical company, announced today that it has received FDA approval for a new indication of its XHANCE (fluticasone propionate) nasal spray to treat chronic .